Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
about
Qualitative Versus Quantitative Mammographic Breast Density Assessment: Applications for the US and AbroadIncreased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women.Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics.The origins of breast cancer associated with mammographic density: a testable biological hypothesis.Genetic variation in sensitivity to estrogens and breast cancer risk.Density and tailored breast cancer screening: practice and prediction - an overview
P2860
Q33850485-97C5D2DA-0E20-4E87-807D-03BB42625924Q47681521-D5B85FE8-4A01-49D2-BA2E-F6D49498724CQ52578726-F931EC1F-B5AA-4636-A8FC-51DE05AB6618Q52675432-CF30892F-C452-408F-B892-2825F48D846CQ52728146-BC4135DF-B727-4CF5-9394-D45D5A8EB413Q55521896-FC369433-9314-4FE4-A49E-43E198E86CAAQ58732209-8FD12C52-746D-4B82-8BE5-E11CCD735C95
P2860
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@en
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@nl
type
label
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@en
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@nl
prefLabel
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@en
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@nl
P2093
P2860
P50
P356
P1476
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
@en
P2093
Anne McTiernan
Celia Byrne
Christopher F Martin
Donglin Zeng
Dorothy S Lane
Elodia B Cole
Etta D Pisano
Eunhee Kim
Jennifer D Peck
JoAnn E Manson
P2860
P356
10.1093/JNCI/DJX001
P407
P577
2017-09-01T00:00:00Z